optalgin teva News and latest stories

Teva's new migraine drug helps contain profit fall

Teva has reduced its spending by $2.5 billion since initiating the restructuring last year.

By REUTERS

Hot Opinion

Israel will need to undergo period of reckoning, consider how to move forward - editorial

By JPOST EDITORIAL

Where will we be on April 1? - opinion

By SUSAN HATTIS ROLEF

Israel will suffer because a house divided will not stand - opinion

By CHUCK FREILICH

Brigadier General Ze'ev Snir gives an atomic warning - opinion

By DANIEL GOLDMAN

What are Middle East reactions to the judicial reform? - opinion

By ELIE PODEH

The Jerusalem Post Customer Service Center can be contacted with any questions or requests:
Telephone: *2421 * Extension 4 Jerusalem Post or 03-7619056 Fax: 03-5613699 E-mail: subs@jpost.com
The center is staffed and provides answers on Sundays through Thursdays between 07:00 AM and 14:00 PM and Fridays only handles distribution requests between 7:00 AM and 12:30 PM
For international customers: The center is staffed and provides answers on Sundays through Thursdays between 7AM and 14PM Israel time Toll Free number 1-800-448-9291 Telephone +972-3-761-9056 Fax: 972-3-561-3699 E-mail: subs@jpost.com

optalgin teva

Teva's new migraine drug helps contain profit fall

Africa is splitting into two as new ocean forms, researchers say

Protests continue after Netanyahu suspends judicial reform

As Russian warship ammo destroyed, Ukraine says missile strategy failed

Get your telescopes ready: Five planets to align on Monday

Netanyahu suspends judicial reform: I will not lead Israel to civil war

Israel will need to undergo period of reckoning, consider how to move forward - editorial

Where will we be on April 1? - opinion

Israel will suffer because a house divided will not stand - opinion

Brigadier General Ze'ev Snir gives an atomic warning - opinion

What are Middle East reactions to the judicial reform? - opinion